Poll

Poll: Diagnosing Giant Cell Arteritis

12/05/2019

Stay in the Know

Rheumatology & Arthritis Newsletter

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1

Popular Articles

Adalimumab Dosing Interval Can Be Extended Without Adverse Effects

09/28/2017

Patients with rheumatoid arthritis (RA) and high concentrations of adalimumab can extend their standard dosing interval for adalimumab therapy without losing disease control, according to the findings of a recent...

Patients...

09/28/2017

Rheumatology & Arthritis

FDA Alert

FDA Approves Bimekizumab for PsA, nr-axSpA and AS

09/23/2024

Rebecca Mashaw ;

Already approved for plaque psoriasis, bimekizumab is designed to selectively inhibit interleukin 17A (IL-17A) and interleukin 17F (IL-17F).

Already approved for plaque...

09/23/2024

Rheumatology & Arthritis

News

NSAID Dose Associated With Risk of CVD Among Patients With axSpA

07/16/2024

Rebecca Mashaw ;

Korean researchers found that patients with axial spondyloarthritis who were treated with increasing doses of nonsteroidal anti-inflammatory drugs were at higher risk of heart disease.

Korean researchers found that...

07/16/2024

Rheumatology & Arthritis

Quiz

Coexisting RA and AS

04/28/2021

The coexistence of rheumatoid arthritis and ankylosing spondylitis in one patient is rare, often leading to misdiagnosis. Take our quick quiz and find out which patients present key signs at onset.

The coexistence of rheumatoid...

04/28/2021

Autoimmune

News

Telemedicine Preferred Among Patients With Autoimmune Rheumatic Disease

01/27/2022

A recent study found that patients with autoimmune rheumatic disease were satisfied with video visits and even preferred telemedicine for certain visit reasons.

A recent study found that...

01/27/2022

Autoimmune

Poll: Diagnosing Giant Cell Arteritis

Stay in the Know

Partner Spotlight

Popular Articles

Specialties

Events

Year Round Education

HMP Global Products